Thomas Bohme

Title: Thomas Bohme: Innovator in Pharmaceutical Chemistry

Introduction

Thomas Bohme is a notable inventor based in Nauheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications in cardiovascular health.

Latest Patents

Bohme holds a patent for "Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them." This invention relates to di(hetero)arylcyclohexane derivatives that are valuable pharmaceutical active compounds. These compounds inhibit ATP-sensitive potassium channels in the heart muscle, making them suitable for treating various cardiovascular disorders, including arrhythmias and decreased heart contractility. The invention also addresses the prevention of sudden cardiac death, showcasing its potential impact on public health.

Career Highlights

Thomas Bohme is associated with Sanofi-Aventis, a leading global healthcare company. His work at Sanofi-Aventis has allowed him to focus on innovative solutions in the pharmaceutical industry. With a patent portfolio that includes 1 patent, Bohme has established himself as a key figure in the development of new therapeutic agents.

Collaborations

Throughout his career, Bohme has collaborated with notable colleagues, including Uwe Gerlach and Dirk Gretzke. These collaborations have contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

In summary, Thomas Bohme is an influential inventor whose work in pharmaceutical chemistry has the potential to improve cardiovascular health. His innovative contributions and collaborations highlight the importance of research in developing effective treatments for serious health conditions.